Duncan Williams Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Enhanced Mid Cap Core ETF
FMDE
|
+$20.8M |
| 2 |
Avantis All International Markets Equity ETF
AVNM
|
+$3.89M |
| 3 |
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
|
+$2.45M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.25M |
| 5 |
iShares Core S&P US Value ETF
IUSV
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P MidCap Quality ETF
XMHQ
|
+$952K |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$684K |
| 3 |
ServiceNow
NOW
|
+$656K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$511K |
| 5 |
Fortinet
FTNT
|
+$492K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.88% |
| 2 | Financials | 6.79% |
| 3 | Consumer Discretionary | 2.98% |
| 4 | Healthcare | 2.83% |
| 5 | Industrials | 1.95% |
Similar funds
Duncan Williams Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Duncan Williams Asset Management held 177 positions worth $444M, up 23% from $361M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Duncan Williams Asset Management deployed $38.7M of net new capital in Q2 2026, opening 23 new positions and adding to 69 existing holdings. Its largest new stake was Fidelity Enhanced Mid Cap Core ETF: 533,933 shares worth $21.7M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.3% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Invesco S&P MidCap Quality ETF, an estimated $952K trimmed.
- Duncan Williams Asset Management's largest Q2 2026 buy was Fidelity Enhanced Mid Cap Core ETF: 533,933 shares worth $21.7M.
- Duncan Williams Asset Management added most to Avantis All International Markets Equity ETF in Q2 2026, an estimated $3.89M increase.
- Duncan Williams Asset Management's biggest Q2 2026 reduction was Invesco S&P MidCap Quality ETF, cutting an estimated $952K.
- Duncan Williams Asset Management fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $684K.
- Duncan Williams Asset Management's ten largest holdings make up 57% of its $444M portfolio in Q2 2026.
- Duncan Williams Asset Management opened 23 new positions and closed 5 in Q2 2026.
- Duncan Williams Asset Management's portfolio value rose 23% quarter-over-quarter to $444M.
Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.